APA

Chang A. L. S., Tran D. C., Cannon J. G. D., Li S., Jeng M., Patel R., Van der Bokke L., Pague A., Brotherton R., Rieger K. E., Satpathy A. T., Yost K. E., Reddy S., Sarin K. & Colevas A. D. (20190306). Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study. : Journal of the American Academy of Dermatology.

Chicago

Chang Anne Lynn S, Tran Duy C, Cannon John G D, Li Shufeng, Jeng Mark, Patel Roma, Van der Bokke Lindsay, Pague Alana, Brotherton Richard, Rieger Kerri E, Satpathy Ansuman T, Yost Kathryn E, Reddy Sunil, Sarin Kavita and Colevas A Dimitrios. 20190306. Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study. : Journal of the American Academy of Dermatology.

Harvard

Chang A. L. S., Tran D. C., Cannon J. G. D., Li S., Jeng M., Patel R., Van der Bokke L., Pague A., Brotherton R., Rieger K. E., Satpathy A. T., Yost K. E., Reddy S., Sarin K. and Colevas A. D. (20190306). Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study. : Journal of the American Academy of Dermatology.

MLA

Chang Anne Lynn S, Tran Duy C, Cannon John G D, Li Shufeng, Jeng Mark, Patel Roma, Van der Bokke Lindsay, Pague Alana, Brotherton Richard, Rieger Kerri E, Satpathy Ansuman T, Yost Kathryn E, Reddy Sunil, Sarin Kavita and Colevas A Dimitrios. Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study. : Journal of the American Academy of Dermatology. 20190306.